• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Ryan J. Sullivan, MD


  • Sullivan RJ, Flaherty KT.Resistance to BRAF-targeted therapy in melanoma.Eur J Cancer. 2013 Apr;49(6):1297-304.
  • Frederick DT, Piris A, Cogdill AP, Cooper ZA, Lezcano C, Ferrone CR, Mitra D, Boni A, Newton LP, Liu C, Peng W, Sullivan RJ, Lawrence DP, Hodi FS, Overwijk WW, LizĂ©e G, Murphy GF, Hwu P, Flaherty KT, Fisher DE, Wargo JA.BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.Clin Cancer Res. 2013 Mar 1;19(5):1225-31.
  • Joseph RW, Eckel-Passow JE, Sharma R, Liu P, Parker A, Jakob J, Buchbinder E, Bassett RL, Davies MA, Hwu P, Atkins MB, Sullivan RJ.Characterizing the Clinical Benefit of Ipilimumab in Patients Who Progressed on High-dose IL-2.J Immunother. 2012 Nov;35(9):711-715.
  • Sullivan RJ, Pantanowitz L.New drug targets in Kaposi sarcoma.Expert Opin Ther Targets. 2010 Dec;14(12):1355-66.
  • Frankenthaler A, Sullivan RJ, Wang W, Renzi S, Seery V, Lee MY, Atkins MB.Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma.Melanoma Res. 2010 Dec;20(6):496-500.
  • Sullivan RJ, Atkins MB.Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond.Expert Opin Investig Drugs. 2010 Oct;19(10):1205-16.
  • Panka DJ, Sullivan RJ, Mier JW.An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.Melanoma Res. 2010 Oct;20(5):401-7.
  • Sullivan RJ, Atkins MB.Cytokine therapy in melanoma.J Cutan Pathol. 2010 Apr;37 Suppl 1:60-7. Review.
  • Sullivan RJ, Pantanowitz L, Dezube BJ.Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma.Future Oncol. 2009 Sep;5(7):949-52.
  • Sullivan RJ,Atkins MB.Molecular-targeted therapy in malignant melanoma.Expert Rev Anticancer Ther. 2009 May;9(5):567-81. Review.
  • Sullivan RJ,Pantanowitz L,Casper C,Stebbing J,Dezube BJ.HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.Clin Infect Dis. 2008 Nov 1;47(9):1209-15. Review.